Literature DB >> 6371104

The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine.

L R Lopez, K C Davis, P F Kohler, A L Schocket.   

Abstract

We report a patient with hypocomplementemic urticarial-vasculitis syndrome. This case illustrates the continuum between urticaria and purpura characteristic of hypocomplementemic urticarial-vasculitis syndrome. Clq precipitin was demonstrated in the patient's serum and in the diethylaminoethylcellulose-ion exchange fraction containing only IgG. A skin biopsy specimen of urticarial and purpuric lesions demonstrated leukocytoclastic vasculitis and granular deposition of C3 and Clq in the basement membrane with IgA, IgM, C3, and Clq in postcapillary venules. Serial total hemolytic complement activity and Clq determinations were performed, and the response to several treatment regimens is presented. Symptomatic and serologic improvement was observed only with hydroxychloroquine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371104     DOI: 10.1016/0091-6749(84)90518-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

Review 1.  Urticarial vasculitis and syndromes in association with connective tissue diseases.

Authors:  R A Asherson; R Sontheimer
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

3.  Primary Cutaneous Small Vessel Vasculitis.

Authors:  James P. Russell; Roger H. Weenig
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

Review 4.  [Therapy of vasculitides and vasculopathies].

Authors:  C Sunderkötter; K de Groot
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

Review 5.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 6.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

Review 7.  Localized Forms of Vasculitis.

Authors:  Joana Martins-Martinho; Eduardo Dourado; Nikita Khmelinskii; Pablo Espinosa; Cristina Ponte
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

8.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

Review 9.  Hypocomplementemic urticarial vasculitis syndrome.

Authors:  Luis J Jara; Carmen Navarro; Gabriela Medina; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.686

10.  Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.

Authors:  Kai-Jun Zhu; Pei-Dan Yang; Qiang Xu
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.